• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Respiratorius

2.30 SEK

0.00 %

Less than 1K followers

RESP

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
0.00 %
-16.67 %
+72.93 %
+41.98 %
+39.39 %
-71.25 %
-90.61 %
-97.22 %
-83.93 %

Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was established in 1999 as a spin-off from Lund University. The operations are located in Sweden, where research is conducted in-house, but also through international partners. The company has its headquarters in Lund.

Read more
Market cap
18.18M SEK
Turnover
104.2 SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
All
Press releases
ShowingAll content types

Financial calendar
11/8
2026

Interim report Q2'26

10/11
2026

Interim report Q3'26

9/2
2027

Annual report '26

Regulatory press release6/9/2026, 3:47 PM

Kommuniké från årsstämma den 9 juni 2026 i Respiratorius AB (publ)

Respiratorius
Regulatory press release5/26/2026, 6:33 AM

Respiratorius: Delårsrapport 1, 2026

Respiratorius
Regulatory press release5/15/2026, 8:15 AM

Respiratorius publicerar Årsredovisning för 2025

Respiratorius

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/6/2026, 9:15 AM

Kallelse till årsstämma i Respiratorius AB (publ)

Respiratorius
Press release3/5/2026, 3:15 PM

Respiratorius: Styrelseledamot lämnar styrelsen av hälsoskäl

Respiratorius
Regulatory press release2/10/2026, 7:33 AM

Respiratorius: Bokslutskommuniké 2025

Respiratorius
Regulatory press release12/4/2025, 7:57 AM

Respiratorius: Valberedning inför årsstämman 2026 utsedd

Respiratorius
Regulatory press release11/11/2025, 7:31 AM

Respiratorius: Delårsrapport 3, 2025

Respiratorius
Regulatory press release9/16/2025, 1:51 PM

Sista dag för handel med BTA i Respiratorius

Respiratorius
Regulatory press release9/11/2025, 3:07 PM

Respiratorius offentliggör utfall av inlösen av teckningsoptioner serie TO2

Respiratorius
Regulatory press release9/6/2025, 7:38 AM

Respiratorius offentliggör utfall i företrädesemission

Respiratorius
Press release9/2/2025, 1:06 PM

Respiratorius VD ökar sitt deltagande i pågående företrädesemission - bolaget erhåller bekräftande FDA-protokoll och påminner om viktiga datum

Respiratorius
Regulatory press release9/1/2025, 6:32 AM

Respiratorius Receives Meeting Minutes from FDA Pre-IND Meeting

Respiratorius
Regulatory press release9/1/2025, 6:32 AM

Respiratorius erhåller mötesprotokoll från FDA:s pre-IND-möte

Respiratorius
Press release8/28/2025, 6:14 AM

BioStock: Läkare vill förskriva Respiratorius VAL001

Respiratorius
Regulatory press release8/20/2025, 6:30 AM

Respiratorius offentliggör informationsdokument avseende företrädesemission och information om TO2

Respiratorius
Regulatory press release8/12/2025, 6:40 AM

Respiratorius: Halvårsrapport 2025

Respiratorius
Regulatory press release8/12/2025, 6:35 AM

Respiratorius beslutar om en företrädesemission om cirka 18,9 MSEK

Respiratorius
Regulatory press release8/12/2025, 6:30 AM

Respiratorius has conducted a pre-IND meeting with the FDA

Respiratorius
Regulatory press release8/12/2025, 6:30 AM

Respiratorius har genomfört pre-IND-möte med FDA

Respiratorius